Trial met primary endpoint, showing Ronapreve significantly reduced viral load in seronegative patients hospitalised with COVID-19 who did not require high-flow oxygen or mechanical ventilation at baselineClinical
Antibody cocktail for Covid emerges as ray of hope, but cost makes it prohibitive for most
Akanksha Chawala, a critical care pulmonologist at Apollo hospital in Delhi, said she had used the therapy in just two patients but the results had been extraordinary.
Share Via Email
| A+A A-
An artist paints No mask No Entry graffiti at Chennai Central Railway station. (File Photo | Martin Louis, EPS)
Express News Service
NEW DELHI: A month after an antibody cocktail was approved for treating mild to moderate Covid-19 in high-risk patients in India, some leading private hospitals in the country have said that they have achieved remarkable results with its usage so far.
Doctors call monoclonal antibody cocktail ‘first Covid treatment’
SECTIONS
Share
Synopsis
The antibody cocktail is a combination of Casirivimab and Imdevimab, which are laboratory made monoclonal antibodies. The cocktail works just like antibodies produced in the human body in response to any viral infection.
Getty Images
The initial use of monoclonal antibody cocktail, the combination of drugs used on former US President Donald Trump and given emergency use approval in India in early May, has given encouraging results, with doctors involved touting it as the “first real treatment for Covid-19”.
Eight-four-year-old Mohabbat Singh, a resident of Haryana, was the first patient in India to be administered the antibody drug cocktail at Medanta Medicity, Gurugram, on May 25. The doctor treating him, Sushila Kataria, told ET, “the patient has tested negative. We have administered the drug cocktail to 15 patients so far. All are fine. This is the first real treatment for Co
Jury is still out on antibody cocktail therapy for covid
Jury is still out on antibody cocktail therapy for covid
BySridhar VivanSridhar Vivan / Jun 2, 2021, 06:00 IST#2021-06-02T06:00:00+05:30
Not all experts are equally enthusiastic about use of a mix of
monoclonal antibodies to treat the infection
There is a debate among health experts over the usage of an antibody cocktail therapy, that had gained fame after then US president
Donald Trump was said to have been administered when he got covid. As a few hospitals in the country have begun using this therapy, there is not much consensus over its effectiveness.